Press Releases
June 1, 2021
Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program
April 6, 2021
ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision
February 23, 2021
AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
January 12, 2021
Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Device
August 25, 2020
AI-based OCT analysis of AREDS2 10-Y follow-on study demonstrates superior performance over retina specialists
Media enquiries? Reach out to our Media Contact